Improved method for treating mammals with modified mammalian blood
CA 2271190 A1 · Owner: Unknown · Inventors: Unknown
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An improved method for treating or preventing a pathological condition in a mammalian, subject in which modified mammalian blood is administered to the subject. The method comprises, administering to the subject at least two courses of treatment each course of , treatment, comprising administration to the subject of 1 or 2 aliquots of the modified mammalian blood. The, courses of treatment are separated from each other by a period of from about 3 to about 21 days. The treatment is useful for treating or preventing a wide range of pathological conditions in which, modified mammalian blood is effective including preconditioning a mammalian subject to better, withstand the adverse …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 6, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 6, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 6, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.